Outcomes of pediatric oncology and hematopoietic cell transplant patients receiving extracorporeal membrane oxygenation

Abstract

Background/objectives:

There is controversy regarding the utilization of extracorporeal membrane oxygenation in pediatric patients with an underlying oncologic diagnosis or who have undergone hematopoietic cell transplant. We hypothesized that these patients have higher mortality, more bleeding complications, more blood product utilization, and a higher rate of new infections than the general pediatric intensive care unit population supported with extracorporeal membrane oxygenation.

Design/methods:

This is a retrospective chart review at a single center quaternary care pediatric hospital including all pediatric intensive care unit extracorporeal membrane oxygenation patients from 2011 to 2016. Patients were categorized as either oncology/hematopoietic cell transplant or general pediatric intensive care unit. Patients from the cardiovascular intensive care unit or the neonatal intensive care unit were excluded.

Results:

A total of 38 patients met inclusion criteria of which 7 were oncology/hematopoietic cell transplant patients. The oncology/hematopoietic cell transplant group had lower platelets at the start of extracorporeal membrane oxygenation (p = 0.02) but other pre-extracorporeal membrane oxygenation characteristics were similar. Extracorporeal membrane oxygenation survival was lower in the oncology/hematopoietic cell transplant group (29% vs 77%, p = 0.02). The incidence of bleeding complications and new infections did not differ. The oncology/hematopoietic cell transplant group received more platelets (median of 15.9 mL/kg/day (interquartile range 8.4, 36.6) vs 7.9 mL/kg/day (3.3, 21.9), p = 0.04) and fresh frozen plasma (14.0 mL/kg/day (3, 15.7) vs 1.8 mL/kg/day (0.5, 5.9), p = 0.04).

Conclusion:

Oncology and hematopoietic cell transplant patients had a higher mortality and received more blood products while on extracorporeal membrane oxygenation than the general pediatric intensive care unit patients despite similar pre-extracorporeal membrane oxygenation characteristics. Physicians should use caution when deciding whether or not to utilize extracorporeal membrane oxygenation in this population.

Keywords

Keywords extracorporeal membrane oxygenation medical oncology heart failure mortality pediatrics critical care

Get full access to this article

View all access options for this article.

References

Smith

Hare

ML.

An overview of progress in childhood cancer survival. J Pediatr Oncol Nurse 2004; 21: 160–164.

BenAbraham

Toren

Ono

et al. Predictors of outcome in the pediatric intensive care units of children with malignancies. J Pediatr Hematol Oncol 2002; 24: 23–26.

Rowan

Gertz

Tamburro

et al. Invasive mechanical ventilation and mortality in pediatric hematopoietic stem cell transplantation: a multicenter study. Pediatr Crit Care Med 2016; 17: 294–302.

Erickson

Schibler

Numa

et al. Acute lung injury in pediatric intensive care in Australia and New Zealand: a prospective, multicenter, observational study. Pediatr Crit Care Med 2007; 8: 317–323.

Pettignano

Fortenberry

Heard

et al. Primary use of the venovenous approach for extracorporeal membrane oxygenation in pediatric acute respiratory failure. Pediatr Crit Care Med 2003; 4: 291–298.

Flori

Dahmer

Sapru

et al. Comorbidities and assessment of severity of pediatric acute respiratory distress syndrome: proceedings from the pediatric acute lung injury consensus conference. Pediatr Crit Care Med 2015; 16: S41–S50.

Rowan

Smith

Loomis

et al. Pediatric acute respiratory distress syndrome in pediatric allogeneic hematopoietic stem cell transplants: a multicenter study. Pediatr Crit Care Med 2017; 18: 304–309.

Rowan

Fitzgerald

Gertz

et al. Pediatric acute respiratory distress syndrome in hematopoietic stem cell transplant recipients. Pediatr Crit Care Med 2015; 43: 96–97.

Lindell

Gertz

Rowan

et al. High levels of morbidity and mortality among pediatric hematopoietic cell transplant recipients with severe sepsis: insights from the SPROUT international point prevalence study. Pediatr Crit Care Med 2017; 18: 01338.

10.

Lewandoski

Extracorporeal membrane oxygenation for severe acute respiratory failure. Crit Care 2000; 4: 156–168.

11.

Annich

Lynch

Maclaren

et al. Extracorporeal cardiopulmonary support in critical care. 4th ed. Ann Arbor, MI: Extracorporeal Life Support Organization, 2012.

12.

Bailly

Reeder

Zabrocki

et al. Development and validation of a score to predict mortality in children undergoing extracorporeal membrane oxygenation for respiratory failure: pediatric pulmonary rescue with extracorporeal membrane oxygenation prediction score. Crit Care Med 2017; 45: e58–e66.

13.

O’Neill

Schutze

Heulitt

et al. Nosocomial infections during extracorporeal membrane oxygenation. Intensive Care Med 2001; 27: 1247–1253.

14.

Gow

Heiss

Fortenberry

et al. Extracorporeal life support for support of children with malignancy and respiratory or cardiac failure: the extracorporeal life support experience. Crit Care Med 2009; 37: 1308–1316.

15.

Coffin

Bell

Manning

et al. Nosocomial infections in neonates receiving extracorporeal membrane oxygenation. Infect Control Hosp Epidemiol 1997; 18: 93–96.

16.

Smith

Butt

Best

et al. Long-term survival after extracorporeal life support in children with neutropenic sepsis. Intensive Care Med 2016; 42: 942–943.

17.

Gow

Wulkan

Heiss

et al. Extracorporeal membrane oxygenation for support of children after hematopoietic stem cell transplantation: the Extracorporeal Life Support Organization experience. J Pediatr Surg 2006; 41: 662–667.

18.

DiNardo

Locatelli

Palmer

et al. Extracorporeal membrane oxygenation in pediatric recipients of hematopoietic stem cell transplantation: an updated analysis of the Extracorporeal Life Support Organization experience. Intensive Care Med 2014; 40: 754–756.

19.

Harris

Taylor

Thielke

et al. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42: 377–381.

20.

Kumar

Sharma

Sethi

et al. Vasoactive Inotrope Score as a tool for clinical care in children post cardiac surgery. Indian J Crit Care Med 2014; 18: 653–658.

21.

Indiana University Department of Pediatrics. http://pediatrics.iu.edu/sections-and-faculty/intensive-care/vvr-calculator/

22.

Barbaro

Paden

Guner

et al. Pediatric extracorporeal life support organization registry international report 2016. ASAIO J 2017; 63: 456–446.

23.

Tamburro

Barfield

Shaffer

et al. Changes in outcomes (1996-2004) for pediatric oncology and hematopoietic stem cell transplant patients requiring invasive mechanical ventilation. Pediatr Crit Care Med 2008; 9: 270–277.

24.

Rowan

Gertz

McArthur

et al. Invasive mechanical ventilation and mortality in pediatric hematopoietic stem cell transplantation: a multicenter study. Pediatr Crit Care Med 2016; 17: 294–302.

25.

Wickiser

Thompson

Leavey

et al. Extracorporeal membrane oxygenation (ECMO) initiation without intubation in two children with mediastinal malignancy. Pediatr Blood Cancer 2007; 49: 751–754.

26.

Prabhu

Mos

Karl

et al. Extracorporeal life support in the acute management of tumour lysis syndrome. Interact Cardiovasc Thorac Surg 2012; 15: 568–569.

27.

Huang

Owen

Myers

et al. Cardiopulmonary failure requiring ECMO bypass resulting from leukemia cell lysis in a patient with childhood acute myelomonocytic leukemia. Case Rep Hematol 2015; 2015: 640528.

28.

Pavlu

Auner

Pello

et al. Analysis of hematopoietic recovery after autologous transplantation as method of quality control for long-term progenitor cell cryopreservation. Bone Marrow Transplant 2017; 52: 1599–1601.

29.

Moynihan

Johnson

Roy

et al. Coagulation monitoring correlation with heparin dose in pediatric extracorporeal life support. Perfusion 2017; 32: 675–685.

30.

O’Meara

Alten

Goldberg

et al. Anti-Xa directed protocol for anticoagulation management in children supported with extracorporeal membrane oxygenation. ASAIO J 2015; 61: 339–344.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.09 MB